The pharmacology of S 1702, a new highly effective oral antibiabetic drug with unusual properties. 1. Pharmacological and hypoglycaemic activity, studies in different animal species.
D000284:Administration, Oral; D000818:Animals; D001786:Blood Glucose / Q000032:analysis; D055598:Chemical Phenomena; D002621:Chemistry; D003517:Cyclopentanes / Q000494:pharmacology; D004285:Dogs; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005951:Glucose Tolerance Test; D006168:Guinea Pigs; D007003:Hypoglycemia / Q000139:chemically induced; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000494:pharmacology*; D007275:Injections, Intravenous; D007328:Insulin / Q000378:metabolism; D000078790:Insulin Secretion; D007928:Lethal Dose 50; D008297:Male; D051379:Mice; D011758:Pyrroles / Q000494:pharmacology; D011817:Rabbits; D051381:Rats; D013453:Sulfonylurea Compounds / Q000008:administration & dosage / Q000494:pharmacology*; D014044:Tolbutamide / Q000494:pharmacology
D001786:Blood Glucose; D003517:Cyclopentanes; D005230:Fatty Acids, Nonesterified; D007004:Hypoglycemic Agents; D007328:Insulin; D011758:Pyrroles; D013453:Sulfonylurea Compounds; D014044:Tolbutamide